An Observational Study of Human Umbilical Cord Tissue Allografts for Paraspinal Muscle and Entheses Defects in the

Conrad Tamea1, Jeff Buchalter2, Jason Capra2

  • 1Orthopedic Associates of Tampa Bay, 4505 N Armenia Ave #101, Tampa, FL 33603, USA.

Biomedicines
|May 27, 2026
PubMed

Insights

Human umbilical cord tissue allografts (UCTAs) show preliminary effectiveness in reducing pain and improving function for patients with paraspinal muscle degeneration. Further research is needed to confirm findings and optimize treatment protocols.

Area of Science:

  • Regenerative Medicine
  • Orthopedics
  • Biomaterials

Background:

  • Paraspinal muscle degeneration, often linked to aging and injury, leads to connective tissue damage and lower back pain (LBP).
  • Human umbilical cord tissue allografts (UCTAs) offer a collagen-rich matrix that can potentially replace degenerated connective tissue.

Purpose of the Study:

  • To analyze preliminary findings on the use of UCTAs for supplementing degenerated thoracic and lumbar paraspinal muscles.
  • To evaluate UCTAs in patients refractory to standard conservative treatments for LBP.

Main Methods:

  • An observational repository study included 117 patients with paraspinal muscle degeneration.
  • Patients received one to three UCTA applications.
  • Outcomes were assessed using the Numeric Pain Rating Scale (NPRS), WOMAC, and Quality-of-Life Scale (QOLS).

Main Results:

  • All patient groups demonstrated improvements in NPRS and WOMAC scores.
  • Multiple UCTA applications showed statistically significant improvements.
  • No adverse events or complications were reported during the study.

Conclusions:

  • This pilot study suggests UCTAs may be effective for paraspinal muscle degeneration and LBP.
  • Further randomized controlled trials are necessary to validate efficacy and establish optimal dosage.
  • Comparative studies against other conservative interventions are recommended.

Related Concept Videos